Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOLAP: Gem/nab-Pac vs FOLFIRINOX in LAPC
NCT02125136Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Nov 2014
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in pancreatic ductal adenocarcinoma (PDAC), sponsored by AIO-Studien. Started Nov 2014; status: completed.
02
Drugs
paclitaxel
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02125136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125136.